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Introduction: Capgras syndrome is a delusional misidentification syndrome characterized by the patient’s belief
that his or her relatives have been replaced by impostors.
Case presentation: Here we describe the clinical picture and the therapeutic approach to an 11-year-old Caucasian
girl with Capgras syndrome. A complete psychopathological assessment was conducted during the acute phase, at
one month, two months and six months since diagnosis.
Conclusion: Subsequent follow-up evaluations in this patient allowed us to detect improvements in the psychotic
symptoms following treatment with risperidone and selective serotonin reuptake inhibitors, suggesting that this
combined therapy may significantly improve the clinical outcome in patients who have Capgras syndrome.
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Capgras syndrome [1] is a monothematic delusion charac-
terized by the patient’s belief that his or her relatives have
been replaced by impostors who have a close resemblance
to the originals [2]. Previous reports in adults referred
to this syndrome as a secondary manifestation of neu-
rodegenerative syndromes, such as Alzheimer disease
or patients showing brain damage, especially in the
right frontal or in the left temporal lobe [3,4]. Indeed,
other studies described a similar clinical picture in
patients with an ‘at risk’ mental state or schizophrenia
and borderline cognitive level [5,6]. Gender comparison
reveals a higher prevalence in females than in males, with
a 2:1 ratio. However, only a few reports have described this
syndrome in male patients during childhood [2,7] and, to
our knowledge, only one case has been reported for a girl:
a 12-year-old girl who had been hospitalized for attacks of
abdominal pain [8]. Neuroleptic drugs are widely used for
the treatment of psychotic symptoms in children and ado-
lescents, for whom they are considered currently the best
option [9]. Neuroleptic drugs have also been used in
patients with Capgras syndrome [10], although without
a complete remission of the positive symptoms. A pre-
vious study [11] showed a positive outcome in a patient* Correspondence: gigimazzone@yahoo.it
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reproduction in any medium, provided the orwith Capgras syndrome after treatment with an anti-
depressant drug (mirtazapine). In the present report,
we outline the clinical picture of an 11-year-old girl
diagnosed with Capgras syndrome, showing signs of
psychotic depression and the therapeutic approach that
was chosen for her.
Case presentation
An 11-year-old Caucasian girl with acute delusions and
aggressive behavior was admitted to our acute in-patient
Child Psychiatry Unit.
This patient was the first child of non-consanguineous
parents, born at term by Caesarean section with a birth
weight of 3,450kg. The neonatal period was regular, with
maternal nursing. Autonomous walking occurred at 14
months and the first words were spoken at 12 months
with a subsequent normal language development.
The patient showed normal learning abilities and good
social skills before the onset of the psychiatric symp-
toms, even if her parents described her as ‘shy’ and with
low social initiative; moreover, they reported behavioral
modifications with a reduction of interests and social
withdrawal a few months before the beginning of delu-
sional symptoms. Her emotional relationship toward her
parents was reserved and unstable.
A month before admission to the in-patient unit the girl
started to develop suspicious thoughts with obsessiveal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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parents, accompanied by a high level of anxiety. These
symptoms soon worsened and the patient was referred to
the Emergency Service for a clinical picture characterized
by auditory hallucinations and persecutory delusions
towards her parents. In detail, she believed that, after a
short trip, her parents had been replaced by impostors
and that the ‘new’ persons replacing them were planning
to poison and kill her. At this point she showed a depres-
sive mood with frequent sadness and crying, loss of energy
and difficulties in sleeping and concentrating. Delusion
was not extended to any other person or inanimate object,
and was not associated with reduplicative paramnesia. Her
parents showed at the time of admission a sense of guilt
and a depressive mood with unsupportive interactions
with their child. At the following visit they revealed an
emotional feeling characterized by difficulties in caring for
their child, frustration, and anger toward the child herself.
Nevertheless, their overall social skills in interaction and
communication were within the normal range [12].
A diagnosis of ‘Delusional Episode’ based on the Diag-
nostic and Statistical Manual of Mental Disorders (4th
edition) was performed using Schedule for Affective
Disorders and Schizophrenia for School-Age Children.
The qualitative pattern of the delusion, concerning the
identity of her parents despite still recognizing the
semblance of their body, is typical of Capgras syndrome,
which is the best known among delusional misidentifica-
tion syndromes [2]. The girl was normal at both physical
and neurological examination. The electroencephalog-
raphy was also normal, whereas the magnetic resonance
imaging (MRI) showed a cerebellar arachnoid cyst of non-
pathological relevance. The results of other diagnostic
tests including electrocardiography, sequential multiple
analysis comprehensive metabolic panel, complete blood
count, serum electrophoresis and thyroid function, were
within normal range.
A complete psychopathological assessment was con-
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PANSS, Positive and Negative Syndrome Scale.(T1), three months (T2) and six months (T3). Between T0
and T1 the patient was treated with risperidone 3mg per
day, and between T2 and T3 50mg per day of sertraline
was added to the risperidone.
At T0 (no medication) the girl showed a full-scale
intelligence quotient of 82 using the Wechsler Intelligence
Scale for Children-III (Verbal Scale score: 86; Performance
Scale score: 82), a Children’s Global Assessment Scale
score of 39, high levels of depressive symptoms with a
Children’s Depression Inventory score of 27, and a score
of 71 on the Multidimensional Anxiety Scale for Children
for anxiety symptoms. The Positive and Negative Symp-
tom Scale (PANSS) for schizophrenia revealed a positive
subscale score of 22, a negative subscale score of 20, a
general psychopathology subscale score of 41 and a total
score of 83. Finally, the girl scored 7 on the Clinical Global
Impression-Severity (CGI-S) scale.
At T1 (after one month of treatment with risperidone,
3mg per day), a reduction was observed in the positive
symptoms, including auditory hallucinations, albeit still
relevant. By contrast, the CGI-S showed only a minimal
improvement and no reduction in the depressive symp-
toms was detected (see Table 1). Due to the modest im-
provement of the clinical picture and to the stable high
levels of depressive symptoms and obsessive thoughts,
clinicians decided to introduce an antidepressant in asso-
ciation with risperidone: the choice was sertraline (50mg
per day).
At T2, after two months of combined treatment, a sig-
nificant improvement was observed in all the domains
analyzed, with a full remission of the clinically relevant
psychotic symptoms, as assessed in the clinical setting
and by direct interviews. Finally, a significant reduction
in the severity of symptoms was also detected after six
months (T3) of treatment with risperidone and sertra-
line: the patient started to recognize her parents and the
monothematic delusion characterized by her belief of
parents being replaced by impostors disappeared. More-
over, the PANSS scores for schizophrenia also showed aT2 T3
Two months after addition of
sertraline
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to 19, 12 and 9 at T1, T2, and T3, respectively (see
Table 1).
Discussion
In this report we describe a young girl showing psychotic
symptoms that can be ascribed to a clinical picture of
Capgras syndrome. The etiopathogenesis of this syndrome
seems to involve organic factors and a difficulty in proces-
sing facial recognition, particularly towards a family
member [13]. As a consequence, patients who have this
syndrome are often characterized by the absence of emo-
tional feelings towards persons of their own family [14].
In the literature, difficulty in facial recognition is often
referred to as prosopagnosia. However, people with proso-
pagnosia can recognize an individual when listening to his
or her voice and under this auditory perception they do
not consider the possibility of the other being an im-
poster [15]. An overlapping between Capgras syndrome
and prosopagnosia has been proposed and some authors
have hypothesized this syndrome as the ‘mirror image’ of
prosopagnosia [2,16]. Neuroanatomical findings showed
that the ventral pathway of explicit facial recognition is
altered in prosopagnosia, whereas the dorsal pathway, re-
sponsible for the emotional processing of facial recog-
nition, seems to be conserved. By contrast, in patients
with Capgras syndrome the ventral pathway remains
intact, whereas the dorsal pathway is impaired, provid-
ing a possible explanation for the altered emotional
responses [2].
A critical point of our report is the positive outcome in
response to the combination of an antipsychotic medica-
tion (risperidone) and a selective serotonin reuptake
inhibitor (SSRI). Literature documents the efficacy of
risperidone for the treatment of psychotic symptoms
in children [17,18], supporting the rationale for our inter-
vention. However, the observed increase in depressive and
obsessive symptoms despite a partial remission of the
symptomatology after one month of risperidone therapy
provided the rationale for the concomitant administration
of a SSRI. Besides there is scant available evidence regard-
ing the association between antipsychotic drugs and SSRIs
in children [19]; in this patient this association led to an
improvement in both depressive and obsessive symptoms
as well as to a complete remission of the overall Capgras
clinical picture. Of note, it has been shown that when this
syndrome occurs in a depressive setting its prognosis
follows the comparatively better prognosis of depression
as compared to that of schizophrenia [20,21]. Therefore, it
is possible that the depressive component in the symp-
tomatology of this patient has contributed to the better
outcome of the overall clinical picture.
Despite the fact that risperidone and SSRIs have been
shown to cause severe adverse effects including markedweight gain, sedation, and risk of extrapyramidal symp-
toms, none of these side effects were observed in our
patient.
Conclusion
Capgras syndrome is very rare in childhood. Our case
suggests that a combined treatment of an antipsychotic
medication plus a SSRI can lead to a good clinical out-
come with a remission of the psychotic symptoms.
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